Pharmaceuticals

sslld6.JPG

Bevacizumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Abevmy, Alymsys, Avastin, Avzivi, Avzivi tnjn, Aybintio, Bambevi, Equidacent, Jobevne, Lextemy, Lytenava, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev, and others (including products approved in developing countries and pipeline products), By Application, By Distribution Channel, Region And Segment Forecasts, 2025-2034

Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic act...

View Sample PDF

slld28.JPG

Rituximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, By Application, By Route of Administration, By Molecule Type, By Distribution Channel Region And Segment Forecasts, 2025-2034

Rituximab Biosimilar Market is expected to grow at a 12.3% CAGR during the forecast period for 2025-2034. Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the standard and malignant B cells surface. It is indica...

View Sample PDF

sldddd.JPG

Synthetic Lethality-based Drugs and Targets Market Size, Share & Trends Analysis Report By Type (Monotherapy, Combination Therapy), By Application (Medical Research Institution, Hospital and Clinic), By Region, And By Segment Forecasts, 2025-2034

Synthetic Lethality-based Drugs and Targets Market Size is predicted to witness a 14.5% CAGR during the forecast period for 2025-2034.  Synthetic lethality refers to a genetic and cancer treatment notion in which the simultaneous dysfunction ...

View Sample PDF

Slid23.JPG

Vitamins, Minerals and Supplements CDMO Market Size, Share & Trends Analysis Distribution by Types (Vitamins, Minerals, Dietary Supplements), Dosage Form (Tablets & Capsules, Powder, Softgel), Service Type (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance), Company Size- and Segment Forecasts, 2025-2034

Vitamins, Minerals and Supplements CDMO Market Size is valued at USD 41.74 Bn in 2024 and is predicted to reach USD 97.60 Bn by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034. The Vitamins, Minerals, and Supplements (VMS) C...

View Sample PDF

Lentiviral_Vector_(LVV)_CDMO_Services_Market.JPG

Lentiviral Vector (LVV) CDMO Services Market Size, Share & Trends Analysis Report By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution), By Region, And By Segment Forecasts, 2025-2034

Lentiviral Vector (LVV) CDMO Services Market Size is predicted to record a 9.0% CAGR during the forecast period for 2025-2034. Lentiviral vectors (LVs) CDMO Services are helpful for gene transfer in mammalian cells because they can efficiently tra...

View Sample PDF

Digital_Adoption_Platform_(DAP)_Market.JPG

Digital Adoption Platform (DAP) Market Size, Share & Trends Analysis Report By Deployment Mode (Cloud-based DAP, On-premise based DAP), By Vertical (Information Technology (IT) and Telecom, Healthcare, Financial Service, Retail and E-commerce), Region And Segment Forecasts, 2025-2034

Digital Adoption Platform (DAP) Market Size is predicted to grow with a 17.8% CAGR during the forecast period for 2025-2034. Digital adoption platforms (DAPs) drive end-user adoption by integrating no-code software with desktop, online, and mobile...

View Sample PDF

High-Performance_Liquid_Chromatography_Market.JPG

High-Performance Liquid Chromatography Market Size, Share & Trends Analysis Report, By Product (Instruments, Consumables and Accessories), By Application (Clinical Research, Diagnostics, Forensics and Others), By Region, Forecasts, 2025-2034

High-Performance Liquid Chromatography Market Size was valued at USD 5.31 Bn in 2024 and is predicted to reach USD 8.37 Bn by 2034 at a 4.8% CAGR during the forecast period for 2025-2034. High-performance liquid chromatography allows for the separ...

View Sample PDF

Next_Generation_Drug_Conjugates_Market.JPG

Next Generation Drug Conjugates Market Size, Share & Trends Analysis Report, By Type (Peptide Receptor Radionuclide Therapy, Ligand mediated RNAi Conjugate, Ligand Conjugated Anti Sense Medicine and Peptide Drug Conjugate), By Type of Targeting Ligand (Amino Sugar, Peptide, Lipid, Small Molecule and Virus-like Particles), By Type of Payload (Peptide, Small Molecule, Oligonucleotide, Radionuclide), By Type of Therapy (Monotherapy, Combination Therapy), By Route of Administration, By Target Indications, By Region, Forecasts, 2025-2034

Global Next Generation Drug Conjugates Market Size was valued at USD 2.9 Bn in 2024 and is predicted to reach USD 12.1 Bn by 2034 at a 15.2% CAGR during the forecast period for 2025-2034. The next-generation drug conjugates (NGDCs) market represents...

View Sample PDF

Spatiotemporal_Omics_market.JPG

Spatiotemporal Omics Market Size, Share & Trends Analysis Distribution by Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics, Spatial Metabolomics, Others), Application (Cancer Research, Neuroscience, Drug Discovery and Development, Others) End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) and Segment Forecasts, 2025-2034

Spatiotemporal Omics Market Size is predicted to develop at an 12.3% CAGR during the forecast period for 2025-2034. Spatiotemporal omics is an advanced field that integrates molecular profiling—such as genomics, transcriptomics, proteomics, ...

View Sample PDF

Cancer_Stem_Cells_Market.JPG

Cancer Stem Cells Market Size, Share & Trends Analysis Report, By Type of Cancer (Breast Cancer, Lung Cancer, Brain Cancer, Prostate Cancer, Colorectal Cancer, Others), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation, Others), By Biomarker Type (CD44, CD133, ALDH1, Others), By End-user (Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic Research Institutes), By Region, Forecasts, 2025-2034

Global Cancer Stem Cells Market Size was valued at USD 4.3 Bn in 2024 and is predicted to reach USD 12.6 Bn by 2034 at a 11.4% CAGR during the forecast period for 2025-2034 The Cancer stem cells Industry is a product of the global business community...

View Sample PDF

Categories